1 / 24

Influenza Virus PHA 5601: Pediatric Ambulatory Care Dr. Angela Thornton, PharmD

Influenza Virus PHA 5601: Pediatric Ambulatory Care Dr. Angela Thornton, PharmD. Jaslyn Adams Alesha Daley Corey Gammon Jayme Rentz . Definition.

chesna
Télécharger la présentation

Influenza Virus PHA 5601: Pediatric Ambulatory Care Dr. Angela Thornton, PharmD

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Influenza VirusPHA 5601: Pediatric Ambulatory CareDr. Angela Thornton, PharmD Jaslyn Adams Alesha Daley Corey Gammon Jayme Rentz

  2. Definition • Influenza, commonly known as "the flu," is a very contagious viral infection of the respiratory tract. Influenza affects all age groups, however children are at higher risk than adults.

  3. Etiology • Influenza virus: • Belongs to the family Orthomyxoviridae • Large single-stranded RNA virus • Has 2 major surface proteins that determine serotype • Hemagglutin (HA) • Neuraminidase (NA) • Divided into three types: A, B, and C • Types A and B are primarily responsible for the epidemic disease • Types A and B are further divided into specific serotypic strains • Type C is primarily responsible for sporadic cases of upper respiratory tract disease

  4. Epidemiology • Location: Influenza affects all countries around the world • Transmission: may be transmitted through large liquid droplets (ex: sneezing into the air) or touching contaminated surfaces and then touching eyes, nose, or mouth. A person with influenza may be contagious for up to ten days after the onset of symptoms.

  5. Temporal Pattern: “Flu Season” in the U.S. is generally from October to May with a peak in February. • While everyone is at risk for getting the flu, there are some high risk populations: • Children younger than 5 years old • Adults older than 65 years old • Pregnant Women • Patients with a weakened immune system • Patients with chronic illnesses including: • Asthma • COPD • Cystic fibrosis • HIV/AIDs • Cancer

  6. Pathophysiology • Influenza virus is transmitted from infected mammals through the air by coughs or sneezes, creating a aerosols like effect that contains the influenza virus.

  7. Symptoms • Fever • Typically lasts 2-4 days (100°F or higher under the arm, 101°F orally, or 102°F rectally) • Myalgias • Chills • Headache • Malaise • Anorexia • Coryza • Pharyngitis • Dry cough • May persist for a long period of time

  8. Diagnosis • If flu-like symptoms arise in the midst of flu season or a flu pandemic, the diagnosis is generally geared towards influenza • Flu Season: October through May; peak in February • Laboratory methods to diagnose influenza: • Viral Culture: • If implemented within the first four days of the illness, the virus may be isolated from the nasopharynx via nasopharyngeal swab, nasal swab, or nasal aspirate. • Rapid Influenza Diagnostic Tests: • These test may not detect all strains of influenza, and may not differentiate between Influenza A and Influenza B

  9. Polymerase chain reaction (PCR) • Detects viral RNA in the presence of a virus • Immunosorbent assay • Detects the presence of antigens and antibodies • Serologic testing: • Tests for antibodies in the serum • Needs to be drawn during illness and post illness to confirm influenza • Will not aid in clinical decision making, will only confirm diagnosis • These test should only be implemented if the results will influence the clinical care of the patient or of other patients

  10. Differential Diagnosis

  11. Complications • Otitis media • Pneumonia • Secondary to bacterial infection • Acute myositis • Usually seen with Type B • Myocarditis • Toxic shock syndrome

  12. Treatment & Prevention

  13. Methods • Supportive care • Pharmacological • Nonpharmacological • Alternative medicine and therapies

  14. Supportive Care • Acetaminophen (Tylenol) • 10-15mg/kg/dose orally every 4-6 hours • Ibuprofen (Motrin) • 5-10mg/kg/dose orally every 6-8 hours • Not for children < 6 months

  15. Oseltamivir (Tamiflu) • Mechanism of action • Inhibits Influenza virus neuraminidase, affecting particle release • Indicated for Influenza Type A&B • Used to treat patients at least 2 weeks old and prophylaxis in children 1 year and older • Dosage • 2weeks- 1year: 3mg/kg twice daily for 5 days or 0.5mL/kgf oral suspension • 1-12 years: 10 capsules 30-75mg twice daily • Weight dependent • Adverse Effects • Nausea, vomiting, arrhythmia, swelling of face or tongue, abdominal pain • Monitoring Parameters • Renal function, serum glucose, in diabetic patients signs of unusual behavior

  16. Non-Pharmacalogical • Get plenty of rest • Increase fluid intake • Warm tea • Soup • Frequently wash hands • Give warm bath or warm compress • Avoid contact with sick people

  17. Influenza Vaccine • Types seen in the U.S. • A/California/7/2009 (H1N1) pdm09-like virus • A/Victoria/361/2011 (H3N2)-like virus • B/Wisconsin/1/2010-like virus • Determined based on age • 1 dose is preferred, unless vaccine has never been received • Side effects: • Injection site reaction • Low/ high grade fever • Body aches

  18. MF59 • Used since 1997 as TIV adjunct to seasonal vaccination • Used in children 6-72 months and adults • Must have not previously received influenza vaccine • Combined with trivalent inactivate influenza vaccine (TIV), abbreviated ATIV

  19. Alternative prevention • Mainly for prevention • American ginseng (panaxquinquefolius) • Don’t take with Tylenol • Increase Vitamin D intake • Cinnamon • Hydrogen peroxide in ear • Garlic

  20. References • Nicola J. High, “Molecular Medical Microbiology”2002, Pages 1967–1988 Volume 3, School of Biological Science, University of Manchester, Manchester, UK. <http://www.sciencedirect.com/science/article/pii/B9780126775303503123> • Kliegman, Wright P. Influenza Viruses. In: Saunders, An Imprint of Elsevier. Nelson Textbook of Pediatrics. New York: McGraw-Hill; 2007. chapter 255. • CDC. Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. MMWR 2010;59 (No. RR-8).

  21. Vesikari, Timo et al. Oil-in-Water Emulsion adjuvant with Influenza Vaccine in Young Children. N Engl J Med 2011; 365:1406-1416 • Harper SA, Bradley JS, Englund JA, et al. Seasonal influenza in adults and children—diagnosis, treatment, chemoprophylaxis, and institu- tional outbreak management: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis 2009;48:1003–32. • CDC. Influenza-Associated Pediatric Mortality, 2013. < http://gis.cdc.gov/GRASP/Fluview /PedFluDeath.html>

More Related